Drugs

The ARDD meeting in Copenhagen this month featured new money, old experiments, endless enthusiasm, and a palpable sense of possibility.

The rise of biobanks around the world promised lots of cheap and plentiful human DNA for scientists to study. Here’s how that’s going.

Targeting a key molecule that helps the brain process sensory threats could lead to new treatments for PTSD, migraines, and autism.

Scientists have been scratching at the familiar, annoying phenomenon long enough now to produce a new crop of promising itch drugs.

A new study questions whether depression is really caused by a chemical imbalance.

On track to become a treatment for mental illnesses, growing research shows how psychedelics might also enhance creativity and concentration.

Male contraceptive gels, “night-before” pills that disrupt ovulation, and the brave future of human contraception.

Digital tools, early detection, and better insurance policies can address the coming wave of cognitive decline.

As psychedelic drugs are poised to join the mainstream, what is the role of the prescriber?

Alto Neuroscience wants to use EEG brain biomarkers to better match the right treatment to a person’s needs.